コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ed for NF-kappaB activation by regulation of protein phosphatase 2A.
2 YAP, small t antigen brings it together with protein phosphatase 2A.
3 e 406 in a rapid process that is mediated by protein phosphatase 2A.
4 se 3beta, cyclin-dependent kinase 5, and tau protein phosphatase 2A.
5 olase 15 family members and the A subunit of protein phosphatase 2A.
6 d somatic mutations in PPP2R1A, a subunit of protein phosphatase 2A.
7 that then recruits the catalytic subunit of protein phosphatase 2A.
8 f phosphorylated Akt to dephosphorylation by protein phosphatase 2A.
9 ear region as well as from the inhibition of protein phosphatase 2A.
10 ) sensor calmodulin, protein kinase CK2, and protein phosphatase 2A.
11 up a CAR surface, allowing interaction with protein phosphatase 2A.
12 are mediated by protein kinase C but not by protein phosphatase 2A.
14 ase-mediated restriction of synthesis of the protein phosphatase 2A-A (PP2A-A), a key factor that fac
16 s inhibition was not due to H(2)S release or protein phosphatase 2A activation, which are key propert
17 s [B56alpha, B56gamma, PR72/PR130, and PTPA (protein phosphatase 2A activator)], which when suppresse
18 tion is regulated depending on the sites and protein phosphatase 2A, active in mitosis, is essential
23 to protein kinase C activation and increased protein phosphatase- 2A activity, thereby suppressing HG
26 by DIM may be due, in part, to inhibition of protein phosphatase 2A, an upstream regulator of ATM.
29 chemical analysis showed increased levels of protein phosphatase 2A and reduced levels of activated A
30 y was associated with reduced Tau binding to protein phosphatase 2A and was dependent on Cdk5 but not
31 uced the cleavage of I2(PP2A), inhibition of protein phosphatase 2A, and hyperphosphorylation of Tau,
32 at Rts1, a regulatory subunit of the general protein phosphatase 2A, and Ptr3 have opposing roles in
33 (armadillo/huntingtin, elongation factor 3, protein phosphatase 2A, and the yeast kinase TOR1) or BE
34 in to HEAT (Huntingtin, elongation factor 3, protein phosphatase 2A, and the yeast kinase TOR1) repea
35 /MST1) signaling, stimulates the activity of protein phosphatase 2A, and thereby attenuates the phosp
36 named after Huntingtin, elongation factor 3, protein phosphatase 2A, and yeast kinase TOR1) repeat.
38 identify CIP2A (cancerous inhibitor of PP2A [protein phosphatase 2A]) as a key modulator of mTORC1 an
39 3 (p90 ribosomal S6 kinase type 3) and PP2A (protein phosphatase 2A) at signalosomes organized by the
40 vity through the androgen receptor-STK4/MST1-protein phosphatase 2A axis, which may have important im
42 nd related proteins that bind to and inhibit protein phosphatase 2A/B55, the principal phosphatase fo
44 kinase-3 (GSK-3), and a beta-arrestin-2/AKT/protein phosphatase 2A (beta-arrestin-2/AKT/PP2A) comple
45 t, Cdr2-T166 phosphorylation is regulated by protein phosphatase 2A but not by the Sds23-PP6 pathway.
46 hase kinase 3beta, protein phosphatase 1, or protein phosphatase 2A, but reduces p35 subunit of Cdk5.
48 showed that Len inhibits the haplodeficient protein phosphatase 2A catalytic domain alpha (PP2Acalph
49 e for KPNA1, the mTOR-associated phosphatase protein phosphatase 2A catalytic interacted directly wit
50 dose-dependent increase in the levels of the protein phosphatase 2A catalytic subunit (PP2Ac) but not
51 -155-mediated suppression of the phosphatase protein phosphatase 2A catalytic subunit alpha (PPP2CA).
52 at low mitogen or nutrient levels, mTOR and protein phosphatase 2A catalytically control the constit
54 berrant expression of cancerous inhibitor of protein phosphatase 2A (CIP2A), a recently identified en
55 d by proteins such as cancerous inhibitor of protein phosphatase 2A (CIP2A), protein phosphatase meth
60 key regulatory subunit (B56alpha) of the PP (protein phosphatase) 2A holoenzyme displayed aberrant ac
61 s, of which three (two peptide inhibitors of protein phosphatase 2A (I1PP2A and I2PP2A) and prostagla
62 this is mediated by metabolic activation of protein phosphatase 2A in complex with the B55beta targe
65 e important structural features required for protein phosphatase 2A inhibition, the mechanism of acti
67 ties of tau kinases and phosphatases such as protein phosphatase 2A, irrespective of fisetin treatmen
69 more, we show that a novel host cell factor, protein phosphatase 2A, is involved in NS2 dephosphoryla
70 whereas dephosphorylation by a mitochondrial protein phosphatase 2A isoform and the calcium-calmoduli
71 tion of a beta-arrestin 2-associated pool of protein phosphatase 2A, leading to activation of Akt and
72 related with reduced Akt activity, increased protein phosphatase 2A levels, derepression of FoxO3a, a
73 ulated kinase pathways, and independently of protein phosphatase 2A, liver kinase B1/AMP-activated pr
75 itory effect was caused by BTK inhibition of protein phosphatase 2A-mediated (PP2A-mediated) dephosph
76 a (alpha isoform of the catalytic subunit of protein phosphatase 2A) negatively regulate the adhesion
77 BR1) interacted with the B'' subunit of rice protein phosphatase 2A (OsPP2A B'') and underwent revers
78 untingtin, elongation factor 3, a subunit of protein phosphatase 2A, PI3 kinase target of rapamycin 1
80 d sphingolipids are required to activate the protein phosphatase 2A (PP2A(Cdc55)) to attenuate Swe1 p
82 endometrial cancers harbor mutations in the protein phosphatase 2A (PP2A) Aalpha scaffold subunit en
83 Somatic missense mutations in the Ser/Thr protein phosphatase 2A (PP2A) Aalpha scaffold subunit ge
85 dding yeast, protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) activities have each been
87 Here we analyzed an endogenous inhibitor of protein phosphatase 2A (PP2A) activity called SET, and i
89 ral human malignancies via the inhibition of protein phosphatase 2A (PP2A) activity toward c-Myc.
91 , also called SET, in rat brain, decrease in protein phosphatase 2A (PP2A) activity, abnormal hyperph
96 ells was associated with a lower activity of protein phosphatase 2A (PP2A) and augmented activity of
97 requires inhibition of the tumor suppressor protein phosphatase 2A (PP2A) and expression--but not ac
98 regulates the methylesterification state of protein phosphatase 2A (PP2A) and has been implicated in
99 associated with decreased phosphorylation of protein phosphatase 2A (PP2A) and increased phosphorylat
100 /ERK and its subsequent dephosphorylation by protein phosphatase 2A (PP2A) and inhibition of focal ad
101 regulates the methylesterification state of protein phosphatase 2A (PP2A) and is implicated in cance
102 Non-canonically activated ERK activates protein phosphatase 2A (PP2A) and lengthens cell cycle d
105 dynamics of PIN proteins are affected by the protein phosphatase 2A (PP2A) and the PINOID kinase, whi
106 eres, the cohesin protector shugoshin (Sgo1)-protein phosphatase 2A (PP2A) antagonizes Aurora B and C
107 per in Immunity, Long et al. (2014) identify protein phosphatase 2A (PP2A) as a deactivator of phosph
108 phosphoprotein-32A (ANP32A), an inhibitor of protein phosphatase 2A (PP2A) as a direct target of sphi
110 In this study, we identify serine/threonine protein phosphatase 2A (PP2A) as a key regulator of Bcl-
111 oupled with mass spectrometry, we identified protein phosphatase 2A (PP2A) as a perphenazine target.
112 We identified the A1 subunit of Ser/Thr protein phosphatase 2A (PP2A) as interacting with full-l
114 l that de novo ceramide biosynthesis induced protein phosphatase 2A (PP2A) association directly with
118 of the general serine-threonine phosphatase protein phosphatase 2A (PP2A) can replace ST in this par
121 un with chromatin is positively regulated by protein phosphatase 2A (PP2A) complexes targeted to c-Ju
125 kinase 1 (RACK1) as the regulatory subunit, protein phosphatase 2A (PP2A) dephosphorylates threonine
128 endent PKA activity but specifically reduced protein phosphatase 2A (PP2A) expression and activity in
131 ly conserved serine (Ser)/threonine-specific protein phosphatase 2A (PP2A) functions as a heterotrime
133 eport show that serine (Ser)/threonine (Thr) protein phosphatase 2A (PP2A) has an important role in G
134 a direct interaction between formoterol and protein phosphatase 2A (PP2A) has been described in vitr
135 lation of AM colonization via ABA requires a PROTEIN PHOSPHATASE 2A (PP2A) holoenzyme subunit, PP2AB'
136 reviously reported that PP2A/Balpha, a major protein phosphatase 2A (PP2A) holoenzyme, binds to and d
138 ivation chaperones control the biogenesis of protein phosphatase 2A (PP2A) holoenzymes that contain a
139 otential role and functional significance of protein phosphatase 2A (PP2A) in CaBP4 dephosphorylation
141 23 but not IL-12 was negatively regulated by protein phosphatase 2A (PP2A) in dendritic cells (DC).
142 the role of the receptor and its associated protein phosphatase 2A (PP2A) in macrophage activation.
144 rectly assessed the contribution of CD25 and protein phosphatase 2A (PP2A) in promoting IL-2R signali
145 t of increased expression of the phosphatase protein phosphatase 2A (PP2A) in T cells, as recorded in
146 lst8Delta bypass mutants reveals a role for protein phosphatase 2A (PP2A) in the regulation of TORC2
148 t of rapamycin (mTOR), whereas inhibition of protein phosphatase 2A (PP2A) induced phosphorylation of
151 enyl-4H-1-benzopyran-4-one (Ly294002) or the protein phosphatase 2A (PP2A) inhibitor okadaic acid rev
152 Here, we show that overexpression of the protein phosphatase 2A (PP2A) inhibitor protein PME-1 dr
168 The recruitment of substrates by the ser/thr protein phosphatase 2A (PP2A) is poorly understood, limi
171 erine 3 by interfering with serine/threonine protein phosphatase 2A (PP2A) leads to decreased class s
174 cer of zeste, trithorax (SET)/inhibitor 2 of protein phosphatase 2A (PP2A) oncoprotein binds and inhi
175 termed "targeted chemotherapy" by depleting protein phosphatase 2A (PP2A) or its inhibition using a
183 de novo mutations revealed four mutations in protein phosphatase 2A (PP2A) regulatory subunit B famil
185 We identify Bbeta2, a mitochondria-localized protein phosphatase 2A (PP2A) regulatory subunit, as a n
186 orylation and activation of serine/threonine protein phosphatase 2A (PP2A) regulatory subunit, B56bet
188 beta-arrestin2/protein kinase B (PKB or Akt)/protein phosphatase 2A (PP2A) signaling complex regulate
191 terase-4D3 (PDE4D3), ryanodine receptor, and protein phosphatase 2A (PP2A) to the sarcoplasmic reticu
192 e SET oncoprotein, a potent inhibitor of the protein phosphatase 2A (PP2A) tumor suppressor, is overe
193 in 2 subunits of serine/threonine (Ser/Thr) protein phosphatase 2A (PP2A) were identified in 16 indi
195 sferase that specifically methylates Ser/Thr protein phosphatase 2A (PP2A), a major Tau phosphatase.
197 ated that activation of the tumor suppressor protein phosphatase 2A (PP2A), a negative regulator of m
198 iquitination and blocking the recruitment of protein phosphatase 2A (PP2A), a phosphatase that inhibi
199 tors that could synergize with activation of protein phosphatase 2A (PP2A), a tumor suppressor phosph
201 oblastoma protein (Rb) family member p107 by protein phosphatase 2A (PP2A), a ubiquitously expressed
202 udies, we identified two holoenzyme forms of protein phosphatase 2A (PP2A), ABalphaC and ABdeltaC, as
203 f key regulators of hepatic gluconeogenesis, protein phosphatase 2A (PP2A), AMP-activated protein kin
204 small t (SV40ST) oncoprotein interacts with protein phosphatase 2A (PP2A), an abundantly expressed f
205 e exchange factor (RasGEF) Aimless, RasGEFH, protein phosphatase 2A (PP2A), and a scaffold designated
206 r processes, inhibiting the tumor suppressor protein phosphatase 2A (PP2A), and inhibiting the metast
207 these pathways, including sprouty2 (SPRY2), protein phosphatase 2A (PP2A), and phosphatase and tensi
209 fied a protein serine/threonine phosphatase, protein phosphatase 2A (PP2A), as a MEKK3 phosphatase.
210 blished that Wee1 and Cdc25 are regulated by protein phosphatase 2A (PP2A), but a full understanding
211 xes that appear to act through regulation of protein phosphatase 2A (PP2A), but their functions in ma
213 we show that a regulatory pathway involving protein phosphatase 2A (PP2A), glycogen synthase kinase
217 a protein complex containing Aldob, Akt, and protein phosphatase 2A (PP2A), leading to inhibition of
219 Binding of YAP to MT brings it together with protein phosphatase 2A (PP2A), leading to the dephosphor
220 Exposure of BL41-3 cells to an inhibitor of protein phosphatase 2A (PP2A), okadaic acid, resulted in
222 his study, we show that the tumor suppressor protein phosphatase 2A (PP2A), one of the major Ser/Thr
223 d that, along with the previously identified protein phosphatase 2A (PP2A), pigment aggregation signa
224 mportant myocardial proteins is regulated by protein phosphatase 2A (PP2A), representing a heterotrim
226 suppression of protein phosphatases, such as protein phosphatase 2A (PP2A), that normally counteract
228 discovery of a protein network comprised of protein phosphatase 2A (PP2A), Transducer of Erb-B2 (Tob
229 r suppressor activity of protein phosphatase protein phosphatase 2A (PP2A), which by dephosphorylatin
230 The phosphorylation of Tau is regulated by protein phosphatase 2A (PP2A), which in turn is modulate
231 te require an interaction between E4orf4 and protein phosphatase 2A (PP2A), which is mediated through
235 in mammalian tissue culture cells it induces protein phosphatase 2A (PP2A)-B55- and Src-dependent cel
236 signaling mechanism that involves transient, protein phosphatase 2A (PP2A)-dependent dephosphorylatio
237 amycin-induced Akt phosphorylation involving protein phosphatase 2A (PP2A)-dependent DNA protein kina
239 n be rapidly stimulated by mGluR-induced and protein phosphatase 2a (PP2A)-mediated dephosphorylation
241 d Bub1 kinase and the Sgo1-bound phosphatase protein phosphatase 2A (PP2A)-Rts1 underlie a tension-de
261 on group A (XPA), pygopus homolog 2 (PYGO2), protein phosphatase 2A (PP2A)B subunit, Tat-interactive
262 otic entry biochemical regulators, including protein phosphatase 2A (PP2A-B55/SUR-6), biophysical reg
263 E3 ligase targeting the catalytic subunit of protein phosphatase 2A (PP2A-C) for ubiquitin-mediated d
264 thylation status of the catalytic subunit of protein phosphatase 2A (PP2A-C), but was not associated
267 of a feed forward mechanistic loop involving protein phosphatase 2A [PP2A] and its downstream substra
268 in and zinedin (the regulatory B subunits of protein phosphatase 2A [PP2A]), which interact with CTTN
270 nvestigated whether the catalytic subunit of protein phosphatase 2A (PP2Ac), which is overexpressed i
274 tors of IRF3 and STAT1 activities, including protein phosphatase 2A (PPP2CA) and tripartite motif-con
275 on did not require sTAg interaction with the protein phosphatase 2A protein complex, a tumor suppress
276 ic control of the many CaMKII-controlled and protein phosphatase 2A-regulated physiological processes
277 lex containing the ubiquitin ligase MID1 and protein phosphatase 2A regulates the nuclear localizatio
278 have previously shown that the Dictyostelium protein phosphatase 2A regulatory subunit B56, encoded b
279 s paper, we show, in budding yeast, that the protein phosphatase 2A regulatory subunit Cdc55 couples
280 ulation of Hmg1 phosphorylation requires the protein phosphatase 2A-related phosphatase Ppe1 and its
281 strate that B55beta, a regulatory subunit of protein phosphatase 2A, represents a molecular link betw
284 ial protease LON1, ribosomal protein RPL24A, protein phosphatase 2A subunit A3, a MADS box protein, a
285 deletion of the catalytic subunits of yeast protein phosphatase 2A, suggesting that lower PKA activi
286 f six (A-F) Huntingtin, elongation factor 3, protein phosphatase 2A, target of rapamycin (HEAT) repea
287 ease, and asparaginyl endopeptidase-I2(PP2A)-protein phosphatase 2A-Tau hyperphosphorylation pathway
289 cogene SET, thereby inducing reactivation of protein phosphatase 2A tumor suppressor and inhibition o
291 encodes a regulatory B subunit of the PP2A (protein phosphatase 2A), which plays important roles in
293 The phosphorylation of Tau is regulated by protein phosphatase 2A, which in turn is regulated by in
294 stead, both agents increased the activity of protein phosphatase 2A, which inactivates protein kinase
295 d by the Arabidopsis thaliana B'' subunit of protein phosphatase 2A, which is encoded by the TONNEAU2
296 unit, as well as with protein kinase CK2 and protein phosphatase 2A, which modulate Ca(2+) sensitivit
297 ctivity of the serine/threonine phosphatase, protein phosphatase 2A, which operates at the intersecti
298 ice lacking the Bbeta2 regulatory subunit of protein phosphatase 2A, which we have shown previously a
299 tion and inactivation of a CDK-counteracting protein phosphatase 2A with a B55delta subunit (PP2A:B55
300 cts with protein phosphatase 2A and recruits protein phosphatase 2A with glycogen synthase kinase 3be